Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritis

Area of Science:

• Immunology
• Rheumatology
• Cytokine Biology

Background:

• Interleukin-7 (IL-7) is vital for T-cell development and function, with emerging implications in autoimmune diseases like rheumatoid arthritis (RA).
• Previous studies indicated lower systemic IL-7 in RA patients, contrasting with higher joint expression, suggesting distinct local and systemic roles.
• This study investigated the impact of IL-7 deficiency on T-cell responses in RA patients achieving clinical remission (CR).

Purpose of the Study:

• To explore the consequences of IL-7 deficiency on T-cell responses in RA patients in CR.
• To determine if IL-7 levels correlate with disease relapse or specific T-cell functions.
• To understand the role of IL-7 in modulating T-cell polarization, survival, and regulatory T-cell (Treg) suppression.

Main Methods:

• Analysis of IL-7 levels in RA patients with active disease and in CR.
• Assessment of T-cell responses to phyto-haemagglutinin (PHA), including proliferation and expression of polarization/survival factors.
• Evaluation of regulatory T-cell (Treg) suppression capabilities and their modulation by IL-7.

Main Results:

• 48% of RA patients in CR maintained normal IL-7 levels (>10 pg/ml).
• Lack of IL-7 recovery in CR patients significantly predicted relapse (86% vs. 23%, P=0.0002).
• Serum IL-7 correlated with restored CD4+ T-cell responses to PHA and Th1 polarization factor (T-bet) expression, but not T-cell proliferation or BCL2/BAX levels. Treg suppression capability was linked to circulating IL-7.

Conclusions:

• IL-7 plays a critical role in modulating T-cell function in vivo, potentially explaining differing systemic and joint effects in RA.
• Failure to restore IL-7 levels in CR may indicate a persistently suppressed immune system, increasing relapse risk.
• These findings highlight IL-7 as a potential biomarker for RA relapse and a target for immune modulation.